The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests.Nearly half of those diagnosed with Parkinson’s ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...